RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Binding of naproxen enantiomers to human serum albumin studied by fluorescence and room-temperature phosphorescence
The interaction of the enantiomers of the non-steroidal anti-inflammatory drug naproxen (NPX) with
human serum albumin (HSA) has been investigated using fluorescence and phosphorescence spectroscopy
in the steady-state and time-resolved mode. The absorption, fluorescence excitation, and fluorescence
emission spectra of (S)-NPX and (R)-NPX differ in shape in the presence of HSA, indicating that
these enantiomers experience a different environment when bound. In solutions containing 0.2 M KI,
complexation with HSA results in a strongly increased NPX fluorescence intensity and a decreased
NPX phosphorescence intensity due to the inhibition of the collisional interaction with the heavy atom
iodide. Fluorescence intensity curves obtained upon selective excitation of NPX show 8-fold different
slopes for bound and free NPX. No significant difference in the binding constants of (3.8 ± 0.6)
105 M1 for (S)-NPX and (3.9 ± 0.6) 105 M1 for (R)-NPX was found. Furthermore, the addition of NPX
quenches the phosphorescence of the single tryptophan in HSA (Trp-214) based on Dexter energy transfer.
The short-range nature of this mechanism explains the upward curvature of the Stern–Volmer plot
observed for HSA: At low concentrations NPX binds to HSA at a distance from Trp-214 and no quenching
occurs, whereas at high NPX concentrations the phosphorescence intensity decreases due to dynamic
quenching by NPX diffusing into site I from the bulk solution. The dynamic quenching observed in the
Stern–Volmer plots based on the longest phosphorescence lifetime indicates an overall binding constant
to HSA of about 3 105 M1 for both enantiomers.
201, The authors thank Dr. Gert van der Zwan for stimulating discussions, Kim van den Boom for assistance with the time-resolved fluorescence measurements, the Dutch Foundation for the Advancement of Science (NWO-CW ECHO Grant No. 700.55.014 to I.L.) and the Spanish government (Ramon y Cajal contract RyC-2007-00476 to V.L-V.) for financial support. V.L.-V.'s visit to LaserLaB VU Amsterdam was made possible through the access program of Laserlab-Europe, EU-Integrated Infrastructures Initiative contract 2008-1-228334, project lcvu001484.